What is the recommended treatment for adolescents diagnosed with bipolar disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Adolescents with Bipolar Disorder According to DSM-5

For adolescents with well-defined DSM bipolar I disorder, pharmacotherapy with mood stabilizers (lithium, valproate) and/or atypical antipsychotics is the primary treatment, with psychosocial interventions as essential adjunctive therapy. 1

Pharmacological Management

First-Line Medications

  • Lithium is FDA-approved for adolescents aged 12 years and older for both acute mania and maintenance therapy, with evidence supporting its efficacy in this population 1
  • Olanzapine has demonstrated efficacy in adolescents (ages 13-17) with manic or mixed episodes associated with bipolar I disorder in a 3-week, double-blind, placebo-controlled trial 2
  • Other atypical antipsychotics (aripiprazole, risperidone, quetiapine) are approved for acute mania in adults and commonly used in adolescents, though with limited specific pediatric studies 1, 3

Medication Selection Algorithm

  1. Start with FDA-approved agents for adolescents when possible:

    • Lithium (≥12 years) as monotherapy 1
    • Olanzapine (13-17 years) for acute manic/mixed episodes 2
  2. Consider combination therapy when response is inadequate:

    • Lithium or valproate plus an atypical antipsychotic has shown superior efficacy compared to mood stabilizer monotherapy 1, 2
    • Lower relapse rates were observed when antipsychotic medication was maintained for at least 4 weeks in combination with lithium for adolescents with acute psychotic mania 1
  3. For bipolar depression:

    • Caution with antidepressants as they may trigger manic episodes; only use in combination with mood stabilizers 1, 4
    • Consider lamotrigine as an adjunctive agent for adolescents with bipolar depression based on preliminary evidence 1

Monitoring and Safety Considerations

  • Regular monitoring for metabolic side effects with atypical antipsychotics (weight gain, glucose abnormalities) 2, 3
  • Monitor lithium levels, thyroid and kidney function 1
  • Avoid unnecessary polypharmacy while recognizing that multiple agents are often required for symptom control 1

Psychosocial Interventions

Essential Adjunctive Therapies

  • Psychoeducational therapy for both patient and family regarding symptoms, course, treatment options, and heritability of the disorder 1
  • Relapse prevention strategies focusing on medication adherence, recognition of emergent symptoms, and identification of precipitating factors 1
  • Individual psychotherapy using cognitive-behavioral or interpersonal approaches to support psychological development and symptom monitoring 1, 5

Family-Focused Treatment

  • Family-focused treatment combining psychoeducation, communication enhancement training, and problem-solving skills has shown benefits in reducing manic symptom severity in adolescents with bipolar disorder 1, 5
  • While intensive psychotherapy combined with pharmacotherapy may not hasten recovery or delay recurrence compared to brief psychoeducation with pharmacotherapy, it can reduce manic symptom severity over time 5

Educational and Community Support

  • Address educational needs through school consultation and individualized educational plans 1
  • Consider specialized educational programs, day treatment, or partial hospitalization for severely affected adolescents 1
  • Community consultation and support groups can provide additional resources for patients and families 1

Special Considerations

Diagnostic Clarity

  • Ensure accurate diagnosis using DSM criteria, as bipolar symptoms must be differentiated from other common childhood disorders such as ADHD, disruptive behavior disorders, and PTSD 1, 6, 7
  • Bipolar NOS should be used to describe youths with manic symptoms lasting hours to less than 4 days or with chronic manic-like symptoms 1, 7

Comorbidities

  • Evaluate and address common comorbidities including substance abuse, which has high rates in adolescents with bipolar disorder 1, 4
  • Assess for suicidality, as adolescents with bipolar disorder have high rates of suicide attempts 1

Treatment Challenges

  • Medication non-compliance is a major contributor to relapse; education about the importance of ongoing treatment is essential 1
  • For bipolar disorder NOS, treatment should be tailored to specific symptom presentations rather than following standard protocols for bipolar I disorder 1

By following this evidence-based approach to treating adolescents with bipolar disorder, clinicians can optimize outcomes while minimizing risks associated with both the disorder and its treatments.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and management of bipolar disorders.

BMJ (Clinical research ed.), 2023

Guideline

Diagnostic Criteria for Bipolar Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pediatric Bipolar Disorder and Mood Dysregulation: Diagnostic Controversies.

Adolescent medicine: state of the art reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.